Results
A total of 173 patients underwent arch reconstruction: 32 (18%) had
single-ventricular defect and the remaining 141 (82%) had
double-ventricular physiology. While 60 (35%) patients were operated on
using ACP-CA, the remaining 113 (65%) patients were operated on using
BHAS. Thirty-three (19%) patients underwent surgery for isolated
transverse aortic arch (TAA) hypoplasia and the procedure was performed
in this group without inducing CA. Arch reconstruction and VSD closure
were performed in 63 (36%) patients. Seventy-seven (45%) patients
underwent surgery for either arch reconstruction as well as non-VSD
pathologies (Table 1).